oral prodrug

Related by string. * ORAL . orals . Oral : TULSA Okla. Oral Roberts . hear oral arguments . hears oral arguments . oral arguments . Oral Suspension . Oral Suspension Oral Suspension / prodrugs . Prodrugs . Prodrug : therapeutically inactive prodrug . hypoxia activated prodrug . hydrophobic docetaxel prodrug nanoparticle . XP# Transported Prodrug . oral TLR7 agonist prodrug * *

Related by context. Frequent words. (Click for all words.) 80 liposomal formulation 78 Panzem R 77 forodesine 75 orally bioavailable 75 PEG SN# 75 Sym# 75 Traficet EN 74 Tesetaxel 74 Azedra 74 Epratuzumab 74 Carfilzomib 74 CCX# 74 multi kinase inhibitor 74 anticancer compound 74 HCV protease inhibitor 74 CR# vcMMAE 73 tezampanel 73 elotuzumab 73 PXD# 73 DAVANAT 73 subcutaneous formulation 73 KNS # 73 ganetespib 73 KRN# 73 Dasatinib 73 Pivotal Phase III 72 ALN TTR# 72 HCV protease 72 CYC# 72 NGX# 72 Drug Candidate 72 phase IIb clinical 72 Phase III Clinical Trial 72 HGS ETR1 72 MEK inhibitor 72 humanized anti 72 Pivotal Phase 72 AVE# 72 Metastatic Melanoma 72 RGB # 72 Laquinimod 72 SCH # 72 novel orally administered 71 Initiates Phase 71 Irinotecan 71 Onalta 71 Bortezomib 71 Mipomersen 71 Aurora kinase 71 Intranasal 71 SAR# [004] 71 CA4P 71 cancer immunotherapies 71 epothilone 71 OXi# 71 thymalfasin 71 pseudobulbar affect PBA 71 squalamine 71 Phase 1b trial 71 Vandetanib 71 atacicept 71 #ME# 71 angiogenesis inhibitor 71 luteinizing hormone releasing 70 diabetic neuropathic pain 70 Phase 2a trial 70 Guanilib 70 Preclinical Data 70 MNTX 70 administered subcutaneously 70 sodium Injection 70 CD# antibody [001] 70 GAP #B# 70 Presents Positive 70 HuMax CD# 70 humanized antibody 70 MKC# 70 R sorafenib tablets 70 Octreotide 70 tanespimycin 70 OncoVEX GM CSF 70 NVA# 70 BAL# [001] 70 polymerase inhibitors 70 BAY #-# 70 Bicifadine 70 partial agonist 70 DDP# 70 SERMs 70 immunomodulator 70 BZL# 70 MAP# 70 rNAPc2 70 PEGylated 70 Synavive 70 otelixizumab 70 Monoclonal Antibody 70 ATL# [001] 70 EZN 69 neuroprotective properties 69 eniluracil

Back to home page